{"url_path":"/sec/smmt/8-k/2026-06-11/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Other Events.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-11","source_url":"https://www.sec.gov/Archives/edgar/data/1599298/0001599298-26-000052-index.html","accession_number":"0001599298-26-000052","cik":"0001599298","ticker":"SMMT","issuer_name":"Summit Therapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1599298/0001599298-26-000052-index.html","primary_entity_key":"0001599298","primary_entity_name":"Summit Therapeutics Inc."},"word_count":231,"has_tables":true,"body_markdown":"Item 7.01\n\nOther Events.\n\nSummit Therapeutics Inc. (the “Company”) announced that effective June 10, 2026 it has withdrawn its previously announced proposed underwritten public offering of securities due to market conditions.\n\nAs a result of such termination, no securities will be sold pursuant to the proposed underwritten public offering. This Current Report on Form 8-K is not an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.\n\nIn accordance with General Instruction B.2 of Form 8-K, the information set forth under this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.\n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.\n\n SUMMIT THERAPEUTICS INC.\n\n  \n\n  \n\nDate: June 11, 2026By:/s/ Manmeet S. Soni\n\n  Chief Operating Officer, Chief Financial Officer and Director\n\n  (Principal Financial Officer)"}